Grantham, Mayo, Van Otterloo & Co (GMO)’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-22,275
Closed -$169K 709
2023
Q2
$169K Sell
22,275
-5,625
-20% -$42.9K ﹤0.01% 651
2023
Q1
$223K Sell
27,900
-1,000
-3% -$10.3K ﹤0.01% 647
2022
Q4
$328K Buy
+28,900
New +$315K ﹤0.01% 623
2021
Q3
Sell
-17,956
Closed -$271K 784
2021
Q2
$271K Sell
17,956
-5,800
-24% -$87K ﹤0.01% 674
2021
Q1
$326K Buy
+23,756
New +$368K ﹤0.01% 772

Other funds holding PTVE

Grantham, Mayo, Van Otterloo & Co (GMO)'s PTVE Position: Q3 2023 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q3 2023, closing a stake of 22,275 shares — an estimated $169K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in PTVE in Q1 2021 and held it in 5 quarters. The position peaked at $328K in Q4 2022. 111 funds tracked by Wall St. Rank hold PTVE as of Q3 2023.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Pactiv Evergreen Inc. Common stock position as of Q3 2023 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 22,275 Pactiv Evergreen Inc. Common stock shares in Q3 2023, an estimated $169K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Pactiv Evergreen Inc. Common stock in Q1 2021 and held it in 5 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Pactiv Evergreen Inc. Common stock position peaked at $328K in Q4 2022.
  • 111 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q3 2023.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2023, filed 13 Nov 2023.